BG107042A - Двойни инхибитори на синтезата на холестеролов естер и восъчен естер, за лечение на разсройства на мастната жлеза - Google Patents

Двойни инхибитори на синтезата на холестеролов естер и восъчен естер, за лечение на разсройства на мастната жлеза Download PDF

Info

Publication number
BG107042A
BG107042A BG107042A BG10704202A BG107042A BG 107042 A BG107042 A BG 107042A BG 107042 A BG107042 A BG 107042A BG 10704202 A BG10704202 A BG 10704202A BG 107042 A BG107042 A BG 107042A
Authority
BG
Bulgaria
Prior art keywords
acne
acetyl
disorder
compound
triisopropylphenyl
Prior art date
Application number
BG107042A
Other languages
Bulgarian (bg)
English (en)
Inventor
Reynold Homan
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of BG107042A publication Critical patent/BG107042A/bg

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG107042A 2000-02-02 2002-08-29 Двойни инхибитори на синтезата на холестеролов естер и восъчен естер, за лечение на разсройства на мастната жлеза BG107042A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17977800P 2000-02-02 2000-02-02
PCT/US2001/002190 WO2001056556A2 (en) 2000-02-02 2001-01-23 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders

Publications (1)

Publication Number Publication Date
BG107042A true BG107042A (bg) 2003-04-30

Family

ID=22657957

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107042A BG107042A (bg) 2000-02-02 2002-08-29 Двойни инхибитори на синтезата на холестеролов естер и восъчен естер, за лечение на разсройства на мастната жлеза

Country Status (34)

Country Link
US (2) US6730703B2 (zh)
EP (1) EP1263421B1 (zh)
JP (1) JP2003531113A (zh)
KR (1) KR20020073574A (zh)
CN (1) CN1398182A (zh)
AP (1) AP2002002612A0 (zh)
AT (1) ATE295724T1 (zh)
AU (1) AU781563B2 (zh)
BG (1) BG107042A (zh)
BR (1) BR0107954A (zh)
CA (1) CA2398219A1 (zh)
CR (1) CR6712A (zh)
DE (1) DE60110897T2 (zh)
DZ (1) DZ3288A1 (zh)
EA (1) EA004255B1 (zh)
EE (1) EE200200429A (zh)
ES (1) ES2239145T3 (zh)
GE (1) GEP20043286B (zh)
HR (1) HRP20020717A2 (zh)
HU (1) HUP0301010A3 (zh)
IL (1) IL150865A0 (zh)
IS (1) IS6478A (zh)
MA (1) MA26872A1 (zh)
MX (1) MXPA02007309A (zh)
NO (1) NO20023659L (zh)
NZ (1) NZ520330A (zh)
OA (1) OA12173A (zh)
PL (1) PL357041A1 (zh)
PT (1) PT1263421E (zh)
SK (1) SK10972002A3 (zh)
UA (1) UA75345C2 (zh)
WO (1) WO2001056556A2 (zh)
YU (1) YU57502A (zh)
ZA (1) ZA200206075B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1281399A3 (en) * 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
US20050031699A1 (en) 2003-06-26 2005-02-10 L'oreal Porous particles loaded with cosmetically or pharmaceutically active compounds
JP2007508291A (ja) 2003-10-09 2007-04-05 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 皮脂産生を減少させるためのマロンアミド誘導体を含んでなる医薬組成物
AU2006217529C1 (en) 2005-02-24 2013-03-07 Medicis Pharmaceutical Corporation Crystalline ACAT inhibitor
FR2903999B1 (fr) * 2006-07-19 2008-09-05 Galderma Res & Dev S N C Snc Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
FR2904002A1 (fr) * 2006-07-19 2008-01-25 Galderma Res & Dev S N C Snc Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee
FR2938342A1 (fr) * 2008-11-13 2010-05-14 Galderma Res & Dev Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
WO2010087964A2 (en) 2009-01-28 2010-08-05 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
BR112020025208A2 (pt) * 2018-06-21 2021-03-09 Dermavant Sciences GmbH Formulações tópicas de inibidores de dgat1 e seus métodos de uso

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545977A (en) * 1985-01-11 1985-10-08 G. D. Searle & Co. Compositions and methods for treating severe acne with isotretinoin
US4751026A (en) 1986-03-24 1988-06-14 Warner-Lambert Company Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase
US4722927A (en) 1986-04-28 1988-02-02 Warner-Lambert Company Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase
JPS6323848A (ja) 1986-07-11 1988-02-01 ワ−ナ−−ランバ−ト・コンパニ− Ω−(置換フエニルオキシ)−アルカン酸のアリ−ル−およびアラルキルアミド
US4716175A (en) 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
IE61716B1 (en) 1987-06-02 1994-11-30 Warner Lambert Co Antihyperlipidemic and antiatherosclerotic urea compounds
US5015644A (en) 1987-06-02 1991-05-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
ATE61574T1 (de) 1987-07-02 1991-03-15 Warner Lambert Co N-((2,6-disubstituierte)-phenyl>-harnstoff und - carbamat-inhibitoren der acyl-coenzym a:cholesterol-acyltransferase.
US4999373A (en) 1988-03-30 1991-03-12 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4868210A (en) 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5030653A (en) 1988-03-30 1991-07-09 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5116848A (en) 1988-03-30 1992-05-26 Warner-Lambert Company N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
US4948806A (en) 1988-03-30 1990-08-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4923896A (en) 1989-02-09 1990-05-08 Warner-Lambert Company N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US5155127A (en) 1989-02-09 1992-10-13 Warner-Lambert Company N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US4994465A (en) 1989-02-17 1991-02-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds
AU632809B2 (en) 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
CA2022346A1 (en) 1989-08-04 1991-02-05 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives
MX22406A (es) 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).
TW205037B (zh) 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd
JPH05310678A (ja) 1990-01-22 1993-11-22 Mitsubishi Kasei Corp 1−フェニルアルキル−3−フェニル尿素誘導体
US5362878A (en) 1991-03-21 1994-11-08 Pfizer Inc. Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
ES2125325T3 (es) 1992-01-23 1999-03-01 Pfizer Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos.
WO1993024458A1 (en) 1992-05-28 1993-12-09 Pfizer Inc. New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)
US5565472A (en) 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
US5596001A (en) 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
US5494172A (en) * 1994-05-12 1996-02-27 Miller Compressing Company Magnetic pulley assembly
US6133326A (en) * 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
CA2335559A1 (en) * 1998-06-25 1999-12-29 Tularik Inc. Arylsulfonanilide phosphates
EP1324995A2 (en) * 2000-09-27 2003-07-09 Merck & Co., Inc. Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders

Also Published As

Publication number Publication date
PL357041A1 (en) 2004-07-12
ATE295724T1 (de) 2005-06-15
IL150865A0 (en) 2003-02-12
DE60110897D1 (de) 2005-06-23
US20030060507A1 (en) 2003-03-27
EA200200764A1 (ru) 2002-12-26
EP1263421A2 (en) 2002-12-11
WO2001056556A2 (en) 2001-08-09
NO20023659L (no) 2002-09-25
US6730703B2 (en) 2004-05-04
DE60110897T2 (de) 2006-03-23
DZ3288A1 (en) 2001-08-09
AP2002002612A0 (en) 2002-09-30
CA2398219A1 (en) 2001-08-09
CN1398182A (zh) 2003-02-19
KR20020073574A (ko) 2002-09-27
AU781563B2 (en) 2005-06-02
AU2971801A (en) 2001-08-14
IS6478A (is) 2002-07-19
MXPA02007309A (es) 2002-11-29
UA75345C2 (en) 2006-04-17
EA004255B1 (ru) 2004-02-26
PT1263421E (pt) 2005-08-31
MA26872A1 (fr) 2004-12-20
HUP0301010A2 (hu) 2003-08-28
EP1263421B1 (en) 2005-05-18
EE200200429A (et) 2003-12-15
US20040161393A1 (en) 2004-08-19
CR6712A (es) 2004-01-14
WO2001056556A3 (en) 2002-03-07
YU57502A (sh) 2006-01-16
NZ520330A (en) 2004-02-27
NO20023659D0 (no) 2002-08-01
HUP0301010A3 (en) 2005-03-29
SK10972002A3 (sk) 2003-07-01
OA12173A (en) 2006-05-08
ES2239145T3 (es) 2005-09-16
BR0107954A (pt) 2002-10-22
ZA200206075B (en) 2003-10-30
HRP20020717A2 (en) 2003-12-31
GEP20043286B (en) 2004-07-26
JP2003531113A (ja) 2003-10-21

Similar Documents

Publication Publication Date Title
AU744712B2 (en) Activated vitamin D3 emulsion-type lotions
EP0098743B1 (en) Phenyl alpha-acyloxyacetamide derivates and their therapeutic use
US6492395B1 (en) Topical formulation of alkyl-, phenyl-pyridone
DE68912459T2 (de) Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten.
HUE028549T2 (en) Topical skin care product
EP0699439B1 (en) Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
BR112018070155B1 (pt) Composições farmacêuticas de apremilast
IE60546B1 (en) Steroid lotion
JPH07196497A (ja) アクネ又は脂漏症を阻止するのに適した医薬組成物
PT92148B (pt) Processo para a preparacao de pomada contendo colesterol para o tratamento topico de dermatoses
NZ520487A (en) Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
US4588750A (en) Therapeutic compositions for reducing sebum secretion
BG107042A (bg) Двойни инхибитори на синтезата на холестеролов естер и восъчен естер, за лечение на разсройства на мастната жлеза
EP0784975A1 (en) Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
JPH0899889A (ja) アトピー性皮膚炎治療剤
JP3193028B2 (ja) ニトロイミダゾール系化合物を含むアトピー性皮膚炎治療用の外用剤
EP1700597B1 (en) Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application
JPH0449216A (ja) メラニン抑制剤
KR20030042688A (ko) 캡사이신을 함유한 말초 혈액 순환 장애 치료용 경피제
NZ210943A (en) Dehydroepiandrosterone compositons for skin treatment